Niksan Pharmaceutical is one ofthe leading manufacturer, supplier, distributer and exporter of Prednisolone API and finishedformulation as all dosage forms. Our product Prednisolone is widely used and appreciated by our group companiesand also our customers and users all around the nations. We offer the Prednisolone in very affordable price.
Niksan Pharmaceutical is the suppliers,manufacturer, exporter and trader in the domestic level as well as theinternational market.
Niksan Pharmaceutical provides Prednisolone API in all over Indianstates like Uttarakhand, Pondicherry, Kerala, Andhra Pradesh, Punjab, HimachalPradesh, Chhattisgarh, Jammu & Kashmir, Haryana, Telangana, Goa, TamilNadu, Jharkhand, Karnataka, Rajasthan, Chandigarh, Gujarat, Maharashtra, UttarPradesh, Odisha, Delhi, West Bengal, Assam, Manipur, Bihar, Madhya Pradesh andmany other state.
Niksan Pharmaceutical also exportsPrednisolone API in worlds othercountries like Zimbabwe, Trinidad & Tobago, Zambia, Ghana, Kenya,Singapore, Mauritius, Australia, Malaysia, Tanzania, Uganda, Nigeria, UnitedKingdom, Ireland, Puerto Rico, Iraq, Sri Lanka, France, Nepal, Sudan, Jordan,Thailand, Qatar, Oman, United Arab Emirates, Hong Kong, Taiwan, United States,Kuwait, Bangladesh, Saudi Arabia, Belgium, Pakistan, Morocco, Philippine,Algeria, Canada, New Zealand, South Africa, South Korea, Egypt, Norway,Indonesia, Iran, Switzerland, Vietnam, Greece, Denmark, Israel and many othercountries.
Prednisolone is steroidmedicine which is used to treatment of allergies, inflammatory conditions,autoimmune disorders, and cancers.
SYNONYMS: Delta-Dehydrocortisol,Delta-Dehydrohydrocortisone, Delta-Hydrocortisone, Delta (1)-Dehydrocortisol,Delta (1)-Hydrocortisone, Hydroretrocortine, Metacortandralone, Prdl,Prednisolona, Prednisolone, Prednisolonum
IUPAC NAME: (1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
CAS NO: 50-24-8
MOLECULAR MASS: 360.44 g/mol
STORAGE OF PrednisoloneAPPLICATIONS OF Prednisolone: Prednisolone is used to treatment of immune system disorders, skinand eye conditions, arthritis, blood problems, breathing problem and cancer. Itis used to treatment of some allergic reaction.
HOW TO USE: Take single dose in one day. Prednisolone is available as formof solutions and tablet so you can take by mouth with or without food.
HOW PrednisoloneWORKS: Prednisolonework by loweringthe activity of the immune system.
CONTRAINDICATIONS: If you have any untreated tuberculosis, inactive tuberculosis, herpessimplex infection of the eye, a herpes simplex infection and an infection dueto a fungus kindly avoid Prednisolone. If you have low amount of potassium or magnesium inyour blood or body kindly avoid Prednisolone.
PHARMACOKINETICS OF Prednisolone: Absorption is approximately 70%after oral administration. Half life of Prednisolone is 2.1 to 3.5 hours. Peakplasma concentration of Prednisolone is approximately 113-1343mg/ml. 98%Prednisolone eliminate via urine.
SIDE EFFECTS OF Prednisolone: Commonside effect of Prednisolone is weight gain, Indigestion,sleep problems, Restlessness and sweating a lot.
PRECAUTIONS: Before using this medication, tell your doctor or pharmacist yourmedical history. This drug may make you dizzy so avoid alcohol and do not driveand do not handle machinery. In the rare case you may infected by Prednisolone.This medication may effect on childrenâs height.
CDSCO APPROVAL: Levofloxacin(15mg) + Prednisolone Acetate 10mg per ml eye drops are approved by CDSCO inIndia in11.07.2007
Clotrimazole(10mg) + Methylprednisolone aceponate 1mg/gm of cream is approved by CDSCO inIndia in 12.07.2007
Docetaxelinjection is approved by CDSCO in India in 09.03.2005
MoxifloxacinHCl (5mg) + Prednisolone Acetate (10mg) per ml. (eye drops) are approved byCDSCO in India in 16.10.2007
Prednisolonestearoylglycolate tablet is approved by CDSCO in India inNovember-1970-
Mupirocin(2%) + Methylprednisolone Aceponate (0.1%) Cream is approved by CDSCO in Indiain31.10.2007
Methylprednisolone aceponate-1mg + salicylic acid-50mg tablet is approved by CDSCO inIndia in 19.11.2007
Methylprednisoloneaceponate-1mg + Mupirocin-20mg cream is approved by CDSCO in India in 21.11.2007
PrednisoloneSodium Phosphate Orally Disintegrating Tablet is approved byCDSCO in India in10/15/30mg 26.11.2009
Prednisolonetablet is approved by CDSCO in India in December-1971
Methylprednisolonetablet is approved by CDSCO in India in March-1978
Methylprednisoloneacetate tablet is approved by CDSCO in India in November-1962
MethylprednisoloneTablet 8mg is approved by CDSCO in India in 01.09.2009
Prednisolone+ Ofloxacin tablet is approved by CDSCO in India in 2003
MethylprednisoloneAcrponate topical solution 0.1%is approved by CDSCO in India in 09.04.2007
Gatifloxacin(0.3%) + Prednisolone Acetate (1%) eye drops are approved by CDSCO in India in02.06.2006
Prednisolonestearoylglycolate tablet is approved by CDSCO in India in February-1971
MethylPrednisolone Aceponate Cream (0.1%) is approved by CDSCO in India in 15.06.2006
Lincomycin +Neomycin + Methyl prednisolone is approved by CDSCO in India in
FORMULATIONS AVAILABLE IN MARKET:
Prednisolone10 MG tablets
Prednisolone5 MG tablets
Prednisolone1 %W/V solutions
Prednisolone30 MG tablets
Prednisolone20 MG tablets
Prednisolone40 MG tablets
Prednisolone1 MG tablets
Prednisolone2 MG tablets
Ofloxacin 3MG+Prednisolone 10 MG /ML solutions
Prednisolone5 MG /5ML solutions
Prednisolone15 MG /5MLsolutions
Prednisolone2.5 MG tablet
Moxifloxacin0.5 %W/V+Prednisolone 1 %W/V solutions
Gatifloxacin0.3 %W/V+Prednisolone 1 %W/V solutions
Chloramphenicol0.5 %W/V+Prednisolone 0.1 %W/V solutions
Note: Product protected by validpatents are not offered for sale in countries where such patents are stillvalid and its liability is at Buyers Risk.